Esophagitis in Non-Small Cell Lung Carcinoma Treatment Caused by Pembrolizumab

被引：5
|
作者：
Yoshida, Sonoe [1 ]
Miyamoto, Shuichi [1 ,2 ]
Naruse, Hirohito [1 ]
Ito, Jun [1 ]
Kinosita, Kenji [1 ]
Kudo, Taiki [1 ]
Hatanaka, Kazuteru [1 ]
Yamamoto, Yoshiya [1 ]
Sakamoto, Naoya [2 ]
机构：
[1] Hakodate Municipal Hosp, Dept Gastroenterol & Hepatol, Hakodate, Hokkaido, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷 / 01期
关键词：
D O I：
10.14309/ajg.0000000000000324
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] Oral targeted therapy for the treatment of non-small cell lung carcinoma
    Phillips, William J.
    Leighl, Natasha B.
    Blais, Normand
    Wheatley-Price, Paul
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (16) : E558 - E561
  • [32] Prognostic Indicators for Precision Treatment of Non-Small Cell Lung Carcinoma
    Ghosh, Damayanti Das
    McDonald, Hannah
    Dutta, Rajeswari
    Krishnan, Keerthana
    Thilakan, Jaya
    Paul, Manash K.
    Arya, Neha
    Rao, Mahadev
    Rangnekar, Vivek M.
    CELLS, 2024, 13 (21)
  • [33] Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis
    Gubens, Matthew A.
    Wakelee, Heather A.
    LUNG CANCER-TARGETS AND THERAPY, 2010, 1 : 63 - 76
  • [34] Will perioperative pembrolizumab treatment change perioperative treatment strategies for resectable non-small cell lung cancer?
    Murakami, Shuji
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (01) : 205 - 209
  • [35] A REVIEW OF COST-EFFECTIVENESS STUDIES OF PEMBROLIZUMAB FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Qiao, N.
    Insinga, R.
    Burke, T.
    Lopes, G.
    VALUE IN HEALTH, 2020, 23 : S41 - S42
  • [36] Pembrolizumab-Associated Cutaneous and Pulmonary Sarcoidosis in Non-Small Cell Lung Cancer Treatment
    Sirgi, Yasmina
    Krochmal, Rebecca
    Fleury, Christine M.
    Holmes, Margaret
    Dewitt, Christine A.
    Cardis, Michael
    Kim, Chul
    CLINICAL LUNG CANCER, 2022, 23 (06) : 542 - 546
  • [37] The Efficacy and Safety of Nivolumab, Pembrolizumab, and Atezolizumab in Treatment of Advanced Non-small Cell Lung Cancer
    Chen, Rui
    Tao, Yuquan
    Xu, Xin
    Shan, Liang
    Jiang, Hongyuan
    Yin, Qilei
    Pei, Lingyan
    Cai, Feng
    Ma, Lifang
    Yu, Yongchun
    DISCOVERY MEDICINE, 2018, 26 (143) : 155 - 166
  • [38] ENCEPHALOPATHY FOLLOWING TREATMENT WITH PEMBROLIZUMAB FOR METASTATIC NON-SMALL CELL LUNG CANCER: A CASE REPORT
    Feng, S.
    O'Byrne, K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 54 - 54
  • [39] Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: Diagnosis and treatment
    Hiraki, A
    Ueoka, H
    Yoshino, T
    Chikamori, KI
    Onishi, K
    Kiura, K
    Bessho, A
    Mimoto, J
    Date, H
    Ando, A
    Shimizu, N
    Harada, M
    ONCOLOGY REPORTS, 1999, 6 (01) : 75 - 80
  • [40] Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date
    Vachhani, Pankit
    Chen, Hongbin
    ONCOTARGETS AND THERAPY, 2016, 9 : 5855 - 5866
12345